Delivery Order SPE2DB20D1004-SPE2DB25FNKZA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,041.38 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract utilized competitive procurement procedures with no...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating inflammatory conditions. The contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,477.89 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating autoimmune conditions. This firm fixed price delivery order, awarded on May 14, 2025, with an ultimate completion date of May 15, 2025, was issued without a set-aside designation and represents a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,265.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, and operates under a firm fixed price structure with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,502.00 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on April 29, 2025, is scheduled for ultimate completion by April 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside...
- The Defense Logistics Agency (DLA) awarded a $5,066.24 delivery order contract to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, was competitively awarded without a set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,054.00 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price, non-set-aside contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,411.86 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable pharmaceutical product used for treating inflammatory conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,800.52 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is set for completion by March 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,727.58 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKZADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,044.00 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and utilizes firm fixed price terms. This delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects AmerisourceBergen's significant role as a critical pharmaceutical vendor within the federal medical supply chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/23/25 |